Why is Vaxzevria authorised in the EU? What information is still awaited for Vaxzevria? This means that there is more evidence to come about the vaccine see below , which the company is required to provide Vaxzevria is given as two injections, usually into the muscle of the upper arm
Thrombocytopenia low levels of blood platelets , vomiting, diarrhoea, pain in legs or arms, swelling and redness at the injection site, flu-like illness and asthenia weakness may affect up to 1 in 10 people A very small number of cases of angioedema rapid swelling under the skin have occurred with Vaxzevria, as well as a very small number of cases of capillary leak syndrome fluid leakage from small blood vessels causing tissue swelling and a drop in blood pressure

لقاح أكسفورد

Wise, Jacqui 5 February 2021.

25
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
"A Phase III study to investigate a vaccine against COVID-19"
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
The decision on whether to use the vaccine in pregnant women should be made in close consultation with a healthcare professional after considering the benefits and risks
لقاح أكسفورد
Annex IIA - Manufacturing-authorisation holder responsible for batch release• There were not enough data from the trial to conclude on how well Vaxzevria works for people who have already had COVID-19
"Covid-19: The E484K mutation and the risks it poses" Can people with allergies be vaccinated with Vaxzevria? "A Phase III study to investigate a vaccine against COVID-19"
Mallapaty, Smriti; Callaway, Ewen 2021-03-24 Vaxzevria must also not be given to people who have previously had capillary leak syndrome

كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا

COVID-19 is caused by SARS-CoV-2 virus.

24
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
The adenovirus in the vaccine cannot reproduce and does not cause disease
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
Arrangements for the supply of the vaccine are the responsibility of national authorities
لقاح أكسفورد
What measures are being taken to ensure the safe and effective use of Vaxzevria? The company that markets Vaxzevria will provide monthly safety reports
Department of Health and Social Care Vaxzevria works by preparing the body to defend itself against COVID-19
If, later on, the person comes into contact with SARS-CoV-2 virus, their immune system will recognise it and be ready to defend the body against it Wise, Jacqui 5 February 2021

لقاح أكسفورد

These studies involved around 24,000 people altogether.

1
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
Immunocompromised people can still be vaccinated as they may be at higher risk from COVID-19
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
Most of the participants in these studies were between 18 and 55 years old
كوفاكس: مصر تتلقى أكثر من 850 ألف جرعة من لقاح أسترازينيكا
Can Vaxzevria reduce transmission of the virus from one person to another? Vaxzevria must not be given to people who have had thrombosis with thrombocytopenia syndrome TTS after receiving the vaccine